
Andrew McPherson: A Beacon of Strength in the Fight Against Lung Cancer
Andrew McPherson's journey: From lung cancer diagnosis at 28 to inspiring advocate, highlighting resilience and the unpredictability of health.
13 Results
Andrew McPherson's journey: From lung cancer diagnosis at 28 to inspiring advocate, highlighting resilience and the unpredictability of health.
Navigate discussions about lung health with our guide on 'Talking to Your Doctor about Lung Nodules or Lung Screening.' Learn to effectively communicate with your physician, understand lung screenings, and handle post-conversation emotions. Essential for anyone looking to improve dialogue and knowledge about lung health.
This blog article goes in-depth with everything you need to know about lung nodules and the next steps for treating a lung nodule.
Read insights from Biodesix's CEO, Scott Hutton, as he launches the 2023 Lung Cancer Awareness Month and explains the importance of actionable early detection for NSCLC.
Celebrating Cabrini Day, Biodesix's CEO Scott Hutton reflects on the legacy of Frances Xavier Cabrini and its alignment with our mission. Discover how we're driven by service, community collaboration, and a commitment to transforming personalized diagnostics in Colorado and beyond.
For Lung Cancer Awareness Month Biodesix created an infographic to help explain the problem of lung nodules and how physicians take care of them.
We are committed to supporting patients and health care providers during the COVID-19 pandemic. Biodesix will continue lab operations without disruption to provide diagnostic testing for patients with, or at risk for lung cancer.
The VeriStrat® proteomic test was designed using mass spectrometry combined with our proprietary artificial intelligence platform. View case study!
Biodesix is monitoring the COVID-19 news, including all recommendations from our local, state, and federal health agencies. The world is grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of COVID-19.
Case study on Longitudinal Monitoring for the Emergence of EGFR C797S resistance mutations in NSCLC using blood-based Droplet Digital PCR.